GAL475 COMPOSITIONS AND METHODS OF USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Feb 20, 2025
app pub date -
Aug 13, 2024
filing date -
Aug 13, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods of treating a subject suffering from a metabolic syndrome or disease, diabetes, obesity, overweight, a food intake disorder, hyperphagia, hyperlipidemia, insulin resistance or a method of lowering body weight in a subject are provided. The methods involve administering a composition comprising a compound of Formula I including, for example, GAL475 (1-(2,6-Bis-methylamino-8-propylamino-pyrimido[5,4-d]pyrimidin-4-yl amino)-2-methyl-propan-2-ol), or a pharmaceutically acceptable salt, solvate, hydrate, enantiomer, stereoisomer, tautomer, or isotopic variant thereof, and a pharmaceutically acceptable carrier or excipient, to the subject.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully